Literature DB >> 32267172

Radiotherapy-induced overexpression of exosomal miRNA-378a-3p in cancer cells limits natural killer cells cytotoxicity.

Joséphine Briand1,2,3,4, Delphine Garnier1,2, Arulraj Nadaradjane1,2,3,4, Karen Clément-Colmou1,2, Vincent Potiron1,2,4, Stéphane Supiot1,2, Gwenola Bougras-Cartron1,2,3,4, Jean-Sébastien Frenel1,2, Dominique Heymann1,2, François M Vallette1,2,5, Pierre-François Cartron1,2,3,4,5.   

Abstract

Aim: We here hypothesized that tumor-derived exosomal miRNA (TexomiR) released from irradiated tumors may play a role in the tumor cells escape to natural killer (NK) cells. Materials & methods: Our study included the use of different cancer cell lines, blood biopsies of xenograph mice model and patients treated with radiotherapy.
Results: The irradiation of cancer cells promotes the TET2-mediated demethylation of miR-378 promoter, miR-378a-3p overexpression and its loading in exosomes, inducing the decrease of granzyme-B (GZMB) secretion by NK cells. An inverse correlation between TexomiR-378a-3p and GZMB was observed in murine and human blood samples.
Conclusion: Our work identifies TexomiR-378a-3p as a molecular signature associated with the loss of NK cells cytotoxicity via the decrease of GZMB expression upon radiotherapy.

Entities:  

Keywords:  DNA methylation; NK cells; TET2; exosomal miRNA; glioblastoma; granzyme B; immune response; miR-378; radiotherapy; resistance

Mesh:

Substances:

Year:  2020        PMID: 32267172     DOI: 10.2217/epi-2019-0193

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  11 in total

Review 1.  Exosomal microRNAs (exoMIRs): micromolecules with macro impact in oral cancer.

Authors:  Rajib Dhar; Saurav Mallik; Arikketh Devi
Journal:  3 Biotech       Date:  2022-06-26       Impact factor: 2.893

Review 2.  Exosomal non-coding RNAs have a significant effect on tumor metastasis.

Authors:  Di Wang; Wei Zhang; Chunxi Zhang; Liwei Wang; Heng Chen; Jianbin Xu
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-31       Impact factor: 10.183

Review 3.  Exosomes in cancer immunoediting and immunotherapy.

Authors:  Yarong Zhao; Luotong Liu; Rongze Sun; Guilin Cui; Shuyu Guo; Songren Han; Ziwei Li; Tian Bai; Lesheng Teng
Journal:  Asian J Pharm Sci       Date:  2022-01-04       Impact factor: 9.273

Review 4.  The Advances in Epigenetics for Cancer Radiotherapy.

Authors:  Yuexuan Wang; Yu Han; Yuzhen Jin; Qiang He; Zhicheng Wang
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

5.  Acute lymphoblastic leukemia-derived exosome inhibits cytotoxicity of natural killer cells by TGF-β signaling pathway.

Authors:  Huijun Yu; Tingting Huang; Daming Wang; Lei Chen; Xi Lan; Xintong Liu; Keyan Chen; Haihong He; Shaobo Li; Yiwen Zhou; Jiansheng Xie
Journal:  3 Biotech       Date:  2021-06-04       Impact factor: 2.893

Review 6.  Vesicular Transport of Encapsulated microRNA between Glial and Neuronal Cells.

Authors:  Walter J Lukiw; Aileen I Pogue
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

Review 7.  Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment.

Authors:  Feiya Ma; Jensen Vayalil; Grace Lee; Yuqi Wang; Guangyong Peng
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

Review 8.  Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.

Authors:  Pieterjan Ginckels; Paul Holvoet
Journal:  Yale J Biol Med       Date:  2022-03-31

Review 9.  Exosomes reveal the dual nature of radiotherapy in tumor immunology.

Authors:  Xinru Hu; Yuyue Qiu; Xiaoping Zeng; Hongmei Wang
Journal:  Cancer Sci       Date:  2022-03-07       Impact factor: 6.716

Review 10.  Exosomes as mediators of immune regulation and immunotherapy in cancer.

Authors:  Fernanda G Kugeratski; Raghu Kalluri
Journal:  FEBS J       Date:  2020-10-03       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.